Stock listing
Tradegate:A8D AB Science SA Aktie
German listing (Tradegate) of AB Science SA · home listing Euronext:AB
Follow AB Science SA into a list and get an email when it puts out news.
Home listing price · EURONEXT:AB
€0.541 EUR -0.007 (-1.3%)
Close on Oct 30, 2026 · This listing has no price on 6ix; the price shown is the home listing's, EURONEXT:AB
- Day range
- €0.537 – €0.547 EUROct 30, 2026
- Volume
- 84,023 sharesOct 30, 2026
- Market cap
- €52.22M EURAt the close on Oct 30, 2026 · price × 96.53M shares outstanding
- 52-week range
- €0.501 – €1.610 EURLowest and highest trades, Oct 31, 2025 – Oct 30, 2026
- Traded on an average day
- €262,359 EURMedian day 222,035 shares · last 3 months, Jul 30, 2026 – Oct 30, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| Euronext:AB · Home | €0.541 EUR | -0.007 (-1.3%) | 84,023 | €0.544 | €0.547 | €0.537 | €0.548 | Close on Oct 30, 2026 |
| LSE:0Q77 | €0.53 EUR | -0.022 (-4.0%) | 62 | €0.533 | €0.533 | €0.53 | €0.552 | Close on Oct 27, 2026 |
| Frankfurt:A8D | €0.545 EUR | +0.018 (+3.4%) | — | €0.545 | €0.545 | €0.545 | €0.527 | Close on Oct 30, 2026 |
Daily closes
Last 3 months, Jul 30, 2026 – Oct 30, 2026 · EURONEXT:AB · EUR, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| €0.541 | -0.007 | -1.3% | €0.544 | €0.547 | €0.537 | 84,023 | |
| €0.548 | +0.006 | +1.1% | €0.560 | €0.562 | €0.542 | 34,087 | |
| €0.542 | +0.009 | +1.7% | €0.540 | €0.570 | €0.536 | 129,061 | |
| €0.533 | +0.003 | +0.6% | €0.530 | €0.539 | €0.530 | 22,201 | |
| €0.530 | -0.019 | -3.5% | €0.547 | €0.554 | €0.529 | 73,404 | |
| €0.549 | +0.006 | +1.1% | €0.541 | €0.567 | €0.541 | 49,499 | |
| €0.543 | -0.022 | -3.9% | €0.566 | €0.569 | €0.543 | 75,277 | |
| €0.565 | +0.015 | +2.7% | €0.584 | €0.584 | €0.544 | 88,107 | |
| €0.550 | +0.009 | +1.7% | €0.536 | €0.558 | €0.535 | 44,337 | |
| €0.541 | -0.002 | -0.4% | €0.543 | €0.546 | €0.532 | 60,975 | |
| €0.543 | -0.008 | -1.5% | €0.544 | €0.570 | €0.540 | 133,938 | |
| €0.551 | -0.009 | -1.6% | €0.564 | €0.598 | €0.544 | 345,166 | |
| €0.560 | -0.020 | -3.4% | €0.576 | €0.582 | €0.556 | 154,939 | |
| €0.580 | +0.031 | +5.6% | €0.558 | €0.605 | €0.558 | 419,375 | |
| €0.549 | +0.025 | +4.8% | €0.526 | €0.564 | €0.526 | 177,933 | |
| €0.524 | +0.009 | +1.7% | €0.529 | €0.529 | €0.516 | 47,147 | |
| €0.515 | -0.007 | -1.3% | €0.520 | €0.549 | €0.508 | 242,876 | |
| €0.522 | -0.023 | -4.2% | €0.540 | €0.541 | €0.520 | 137,266 | |
| €0.545 | +0.008 | +1.5% | €0.570 | €0.570 | €0.545 | 212,713 | |
| €0.537 | -0.007 | -1.3% | €0.545 | €0.551 | €0.530 | 112,852 | |
| €0.544 | -0.038 | -6.5% | €0.580 | €0.586 | €0.539 | 556,897 | |
| €0.582 | -0.008 | -1.4% | €0.592 | €0.593 | €0.580 | 266,124 | |
| €0.590 | +0.002 | +0.3% | €0.600 | €0.611 | €0.590 | 312,231 | |
| €0.588 | -0.102 | -14.8% | €0.662 | €0.662 | €0.580 | 1,315,141 | |
| €0.690 | +0.006 | +0.9% | €0.690 | €0.700 | €0.681 | 29,121 | |
| €0.684 | -0.009 | -1.3% | €0.700 | €0.700 | €0.669 | 162,941 | |
| €0.693 | -0.017 | -2.4% | €0.708 | €0.714 | €0.693 | 100,793 | |
| €0.710 | -0.002 | -0.3% | €0.712 | €0.720 | €0.708 | 58,102 | |
| €0.712 | -0.002 | -0.3% | €0.710 | €0.724 | €0.709 | 163,327 | |
| €0.714 | +0.009 | +1.3% | €0.702 | €0.729 | €0.701 | 149,744 | |
| €0.705 | -0.007 | -1.0% | €0.720 | €0.729 | €0.705 | 97,794 | |
| €0.712 | +0.003 | +0.4% | €0.702 | €0.721 | €0.702 | 40,846 | |
| €0.709 | +0.006 | +0.9% | €0.702 | €0.722 | €0.702 | 96,692 | |
| €0.703 | -0.017 | -2.4% | €0.713 | €0.715 | €0.701 | 82,909 | |
| €0.720 | -0.010 | -1.4% | €0.725 | €0.727 | €0.700 | 107,191 | |
| €0.730 | +0.025 | +3.5% | €0.716 | €0.744 | €0.704 | 318,136 | |
| €0.705 | -0.001 | -0.1% | €0.729 | €0.729 | €0.700 | 56,554 | |
| €0.706 | -0.026 | -3.6% | €0.732 | €0.732 | €0.700 | 210,761 | |
| €0.732 | +0.007 | +1.0% | €0.730 | €0.749 | €0.730 | 234,666 | |
| €0.725 | -0.007 | -1.0% | €0.730 | €0.749 | €0.687 | 222,035 | |
| €0.732 | -0.002 | -0.3% | €0.734 | €0.734 | €0.720 | 119,069 | |
| €0.734 | -0.006 | -0.8% | €0.747 | €0.754 | €0.730 | 146,587 | |
| €0.740 | +0.004 | +0.5% | €0.739 | €0.769 | €0.721 | 320,663 | |
| €0.736 | +0.033 | +4.7% | €0.708 | €0.742 | €0.697 | 259,437 | |
| €0.703 | -0.020 | -2.8% | €0.710 | €0.717 | €0.692 | 284,132 | |
| €0.723 | 0.000 | 0.0% | €0.735 | €0.747 | €0.720 | 250,769 | |
| €0.723 | +0.010 | +1.4% | €0.706 | €0.748 | €0.706 | 356,181 | |
| €0.713 | -0.026 | -3.5% | €0.731 | €0.748 | €0.706 | 507,804 | |
| €0.739 | +0.067 | +10.0% | €0.675 | €0.779 | €0.672 | 1,001,446 | |
| €0.672 | -0.021 | -3.0% | €0.676 | €0.681 | €0.660 | 243,333 | |
| €0.693 | 0.000 | 0.0% | €0.692 | €0.704 | €0.667 | 420,834 | |
| €0.693 | -0.016 | -2.3% | €0.700 | €0.715 | €0.680 | 439,488 | |
| €0.709 | -0.003 | -0.4% | €0.706 | €0.720 | €0.680 | 728,655 | |
| €0.712 | -0.007 | -1.0% | €0.720 | €0.720 | €0.705 | 160,573 | |
| €0.719 | -0.025 | -3.4% | €0.740 | €0.741 | €0.712 | 460,296 | |
| €0.744 | +0.024 | +3.3% | €0.728 | €0.745 | €0.715 | 343,966 | |
| €0.720 | -0.011 | -1.5% | €0.701 | €0.740 | €0.700 | 735,151 | |
| €0.731 | -0.040 | -5.2% | €0.752 | €0.778 | €0.731 | 589,361 | |
| €0.771 | +0.025 | +3.4% | €0.750 | €0.823 | €0.740 | 1,504,496 | |
| €0.746 | -0.254 | -25.4% | €0.900 | €0.900 | €0.730 | 2,914,127 | |
| €1.000 | +0.194 | +24.1% | €0.855 | €1.000 | €0.845 | 1,075,191 | |
| €0.806 | +0.104 | +14.8% | €0.748 | €0.872 | €0.731 | 2,311,272 | |
| €0.702 | +0.054 | +8.3% | €0.628 | €0.702 | €0.628 | 277,148 | |
| €0.648 | +0.036 | +5.9% | €0.602 | €0.696 | €0.590 | 754,264 | |
| €0.612 | +0.071 | +13.1% | €0.544 | €0.628 | €0.544 | 704,850 | |
| €0.541 | +0.010 | +1.9% | €0.532 | €0.560 | €0.524 | 499,601 | |
| €0.531 | -0.026 | -4.7% | €0.553 | €0.553 | €0.527 | 441,153 |
- Ticker
- Tradegate:A8D
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- Tradegate
- Currency
- EUR
What changed lately
Latest news release · Oct 12, 2026
AB Science will hold a web conference on Wednesday, October 14, 2026, from 6: 00 p.m. to 7: 30 p.m.
Latest deck · January 2026
Investor Presentation (January 2026)
Investor deck · 33 slides
Latest news
AB Science will hold a web conference on Wednesday, October 14, 2026, from 6: 00 p.m. to 7: 30 p.m.
Oct 12, 2026
Closed €0.549 (+4.8%) on Oct 12, 2026
Revenues for the first half of 2026 and update on AB Science’s activities
Oct 9, 2026
Closed €0.549 (+4.8%) on Oct 12, 2026
AB Science today reports its revenues for the first half of 2026 and provides an update on its activities
Oct 9, 2026
Closed €0.549 (+4.8%) on Oct 12, 2026
AB Science provides an update on its development plan and financial calendar following a sponsor Good Clinical Practice inspection
Sep 29, 2026
Closed €0.588 (-14.8%) on Sep 29, 2026
AB Science fait le point sur son plan de developpement et son calendrier financier à la suite d'une inspection promoteur des bonnes pratiques cliniques
Sep 29, 2026
Closed €0.588 (-14.8%) on Sep 29, 2026
AB Science annonce le succès du règlement-livraison des titres émis dans le cadre de son placement privé de 14,2 millions d’euros annoncé le 10 aout 2026
Aug 16, 2026
Closed €0.719 (-3.4%) on Aug 17, 2026
AB Science announces today the successful completion of capital increases of a total gross amount of EUR 14.2 million
Aug 10, 2026
Closed €0.746 (-25.4%) on Aug 10, 2026
AB Science annonce aujourd’hui le succès d’augmentations de capital d’un montant brut total de 14,2 millions d’euros
Aug 9, 2026
Closed €0.746 (-25.4%) on Aug 10, 2026
AB Science provides an update on its clinical program, suspending some non-priority clinical trials to focus on two clinical programs
Jul 10, 2026
Closed €0.693 (-5.5%) on Jul 13, 2026
Financings
Private placement of new ordinary shares with share warrants attached (ABSA)
Aug 10, 2026 · US$16.4M
Closed: €14.2M raised · €0.61 a share · 1 warrant at €1 for 60 months
Buyers: Existing long-term investor (EUR 12 million); Stéphane Ledermann
Insiders: The CEO, Stéphane Ledermann, also contributed to the financing
Use of proceeds: Fund R&D programs, mainly AB8939 in acute myeloid leukemia, masitinib in ALS, and nearer-term value-creation projects
Decks
Investor Presentation (January 2026)
Investor deck · 33 slides · January 2026
Investor Presentation (March 2025)
Investor deck · 59 slides · March 2025
Corporate Update (December 2024)
Corporate update · 35 slides · December 2024
Investor Presentation (July 2024)
Investor deck · 46 slides · July 2024
AB Science SA on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 29 in the last 12 months · 51 in all · newest Oct 12, 2026 · oldest 2025
- Decks
- 11 decks · latest January 2026
Where AB Science SA is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| Euronext:AB · Home listing | Euronext | France | EUR |
| LSE:0Q77 | LSE | United Kingdom | EUR |
| LS Exchange:A1CXBG | LS Exchange | Germany | EUR |
| OTC:ABSCF | OTC | United States | USD |
| Lang & Schwarz:A1CXBG | Lang & Schwarz | Germany | EUR |
| gettex:A8D | gettex | Germany | EUR |
| Aquis:ABP | Aquis | United Kingdom | EUR |
| Turquoise:ABP | Turquoise | United Kingdom | EUR |
| Aquis:ABP | Aquis | United Kingdom | EUR |
| Dusseldorf:A8D | Dusseldorf | Germany | EUR |
| Frankfurt:A8D | Frankfurt | Germany | EUR |
| Hamburg:A8D | Hamburg | Germany | EUR |
| Munich:A8D | Munich | Germany | EUR |
| Stuttgart:A8D | Stuttgart | Germany | EUR |
| Tradegate:A8D · This page | Tradegate | Germany | EUR |
Log in to ask 6ix AI your own questions about AB Science SA.